Skip to main content
. 2017 May 10;7:1646. doi: 10.1038/s41598-017-01602-w

Figure 3.

Figure 3

(A) 26 compounds were identified to inhibit human Biliverdin Reductase at a concentration of 10 μmol/l during a semi-high-throughput screen of a drug library containing 1280 FDA and EMA approved small molecules. (B) Two compounds were selected for in vivo studies after consideration of safety profile for long-term dosing and possibility of oral administration.